Vedolizumab levels in breast milk: Results from a prospective, postmarketing, milk-only lactation study in nursing mothers with inflammatory bowel disease

被引：0
|
作者：
Sun, W. [1 ]
Fennimore, B. [2 ]
Beaulieu, D. B. [3 ]
Arsenescu, R. [4 ]
Stein, A. [5 ]
Chen, J. [6 ]
Lin, T. [7 ]
McKnight, S. [8 ]
Rosario, M. [9 ]
Lirio, R. A. [10 ]
机构：
[1] Takeda, Quantitat Clin Pharmacol, Cambridge, MA USA
[2] Univ Colorado, Dept Med Gastroenterol, Aurora, CO USA
[3] Vanderbilt Univ, Med Ctr, Vanderbilt Digest Dis Ctr, Nashville, TN USA
[4] AHS Hosp Corp, Morristown Med Ctr, Morristown, NJ USA
[5] Northwestern Univ, Div Gastroenterol & Hepatol, Chicago, IL 60611 USA
[6] Takeda, Stat & Quantitat Sci, Cambridge, MA USA
[7] Certara, Integrated Drug Dev, Princeton, NJ USA
[8] Takeda, Global Program Management, Cambridge, MA USA
[9] Takeda, Clin Pharmacol, Cambridge, MA USA
[10] Takeda, Clin Sci, Cambridge, MA USA
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P509
引用
收藏
页码：S442 / S442
页数：1
相关论文
共 50 条
  • [21] Baseline Drug Clearance Predicts Outcomes in Children With Inflammatory Bowel Disease Treated With Vedolizumab: Results From the VedoKids Prospective Multicentre Study
    Stein, Ronen
    Turner, Dan
    Hussey, Seamus
    Kawasmi, Aysha
    Ledder, Oren
    Levine, Jeremiah
    Markowitz, James
    Matar, Manar
    Orlanski-Meyer, Esther
    Russell, Richard K.
    Shaoul, Ron
    Yerushalmy-Feler, Anat
    Mould, Diane R.
    Conrad, Maire A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (06) : 1000 - 1010
  • [22] Vedolizumab in Indian patients with Inflammatory Bowel Disease: Interim results from a prospective, multicentre, open-label, phase 4 study
    Kabrawala, M.
    Banerjee, R.
    Ahuja, V.
    Anumula, K.
    Bharadwaj, V.
    Dalal, A.
    Kumar, B. Ramesh
    Mukewar, S.
    Sood, A.
    Prasad, V. M.
    Arora, S.
    Kirde, S.
    Sharma, N.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1196 - I1198
  • [23] Influence of Early Life Factors, including breast milk Composition, on the Microbiome of Infants Born to Mothers with and without Inflammatory Bowel Disease
    Sabino, J.
    Tarassishin, L.
    Eisele, C.
    Hawkins, K.
    Barre, A.
    Nair, N.
    Rendon, A.
    Debebe, A.
    Picker, M.
    Agrawal, M.
    Stone, J.
    George, J.
    Legnani, Peter
    Maser, Elana
    Chen, Ching-Lynn
    Thjomoe, Anne
    Mork, Einar
    Dubinsky, M.
    Hu, J.
    Colombel, J. F.
    Peter, I
    Torres, J.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 (11): : 1723 - 1732
  • [24] Effectiveness and persistence of vedolizumab in patients with Inflammatory bowel Disease: Results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE)
    Reenaers, C.
    Cremer, A.
    Dewit, O.
    de Vroey, B.
    Van Moerkercke, W.
    Bossuyt, P.
    Muls, V.
    Imschoot, J.
    Block, S.
    Hantson, A.
    Van Hootegem, P.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S476 - S477
  • [25] Effectiveness and persistence of Vedolizumab in patients with inflammatory bowel disease : results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE)
    Reenaers, C.
    Cremer, A.
    Dewit, O.
    De Vroey, B.
    Van Moerkercke, W.
    Bossuyt, P.
    Muls, V
    Imschoot, J.
    Block, S.
    Hantson, A.
    Van Hootegem, P.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2020, 83 (01) : 15 - 23
  • [26] Protein levels and protease activity in milk from mothers of pre-term infants: A prospective longitudinal study of human milk macronutrient composition
    Caldeo, Veronica
    Downey, Eimear
    O'shea, Carol-Anne
    Affolter, Michael
    Volger, Sheri
    Courtet-Compondu, Marie-Claude
    De Castros, Carlos Antonio
    O'Mahony, James A.
    Ryan, C. Anthony
    Kelly, Alan L.
    CLINICAL NUTRITION, 2021, 40 (05) : 3567 - 3577
  • [27] Cross-sectional study of DDT and its metabolite levels in breast milk from Saudi mothers
    Al-Saleh, I
    Al-Zahrani, M
    Al-Shanshoury, M
    Shinwari, N
    Basile, P
    Al-Doush, I
    Mohammed, GED
    EPIDEMIOLOGY, 2002, 13 (04) : S240 - S240
  • [28] VEDOLIZUMAB DRUG LEVELS IN MATERNAL AND CORD BLOOD FOLLOWING TREATMENT OF INFLAMMATORY BOWEL DISEASE IN PREGNANCY: ONGOING MULTICENTRE PROSPECTIVE STUDY FROM THE CZECH REPUBLIC
    Pipek, Barbora
    Duricova, Dana
    Mitrova, Katarina
    Bortlik, Martin
    Urban, Ondrej
    Lukas, Milan
    GASTROENTEROLOGY, 2020, 158 (06) : S451 - S451
  • [29] STUDY OF THE NITROGEN FRACTIONS OF HUMAN-MILK DURING THE 1ST WEEK OF LACTATION - COMPARISON OF BREAST-MILK FROM MOTHERS OF TERM AND PREMATURE NEONATES
    DEGAMARRA, E
    BAHY, C
    ARCHIVES FRANCAISES DE PEDIATRIE, 1985, 42 : 601 - 604
  • [30] Vedolizumab for Inflammatory Bowel Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study ICC Registry - Vedolizumab
    Biemans, Vince B. C.
    van der Woude, C. Janneke
    Dijkstra, Gerard
    van der Meulen-de Jong, Andrea E.
    Oldenburg, Bas
    de Boer, Nanne K.
    Loewenberg, Mark
    Srivastava, Nidhi
    Bodelier, Alexander G. L.
    West, Rachel L.
    Jansen, Jeroen M.
    de Vries, Annemarie C.
    Haans, Jeoffrey J. L.
    de Jong, Dirk J.
    Pierik, Marie J.
    Hoentjen, Frank
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (05) : 1189 - 1199
12345